# OnCo record da-prasinezumab (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/da-prasinezumab/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "da-prasinezumab" ;
  schema:name "Prasinezumab"@en ;
  schema:description "Prasinezumab is an investigational synuclein antibody studied mainly in Parkinson’s disease. It is not an approved dementia medicine."@en ;
  schema:url <https://onco.cc/drugs/da-prasinezumab/> ;
  schema:dateModified "2026-09-21"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03100149> ;
  onco:status "phase-2" ;
  onco:tag "dementia-atlas" ;
  onco:modality "mAb" ;
  onco:cancers <https://onco.cc/diagnoses/parkinsons-disease-dementia/>, <https://onco.cc/diagnoses/dementia-with-lewy-bodies/> ;
  onco:targets <https://onco.cc/targets/da-target-alpha-synuclein/> ;
  onco:companies <https://onco.cc/companies/da-roche/> ;
  onco:trials <https://onco.cc/trials/da-trial-prasinezumab/> .